全球自动化细胞培养市场规模：按产品类型、按应用、按最终用户、按地区、范围和预测

自动化细胞培养市场规模及预测

2023年，自动化细胞培养市场的市场规模为249亿美元，预计在2024-2030年的预测期内将以8.71%的复合年增长率增长，到2030年将达到455.8亿美元。

全球自动化细胞培养市场的市场推动因素

自动化细胞培养市场的市场推动因素可能受到多种因素的影响。

生物製药需求不断扩大

自动化细胞培养技术对于优化生产流程变得越来越必要。例如疫苗接种、单株抗体、重组蛋白等。

细胞培养技术发展：

先进细胞培养技术的不断发展推动了自动化细胞培养解决方案的激增，包括生物反应器、自动化系统和先进细胞培养基的发展。

慢性病盛行率：

随着糖尿病、癌症和自体免疫疾病等慢性疾病变得越来越普遍，对用于疾病建模、药物开发和个人化治疗的有效细胞培养方法的需求不断增长。

加大生命科学领域的研发力道：

随着製药和生技公司不断投资研发以创造新的治疗方法和疗法，对自动化细胞培养技术以提高效率和生产力的需求不断增加。

关注再生医学：

对组织工程应用和再生医学的日益关注产生了对精确和规范的细胞培养程序的需求，推动了自动化细胞培养系统在细胞药物和组织工程产品生产中的使用。

促进生物技术和生命科学研究的政府支援措施、资助计画和合作伙伴关係正在推动技术进步和商业化努力，进而推动自动化细胞培养市场的成长。

需要节省成本和时间：

细胞培养程序的自动化降低了成本，减少了人为错误的可能性，并加快了生物製药的上市时间。这些优势正在推动产业采用自动化细胞培养解决方案。

对个人化医疗的需求不断增加：

由于基因组学和精准医学的突破性进展，对可扩展且高度可重复的细胞培养系统的需求日益增长，这些系统可以产生针对患者的特异性治疗。这正在推动自动化细胞培养技术市场的发展。

全球自动化细胞培养市场的阻碍因素

有几个因素可能会成为自动化细胞培养市场的限制和课题。

高初始投资：

由于购买和部署自动化细胞培养系统（包括基础设施、软体和设备）所需的初始资本支出，规模较小的生物技术公司和研究机构可能会发现很难进入市场。

整合复杂度：

将自动化细胞培养系统与当前实验室工作流程和基础设施整合起来既困难又耗时。这是因为培训、验证和客製化需要更多的知识和资源，从而降低了采用率。

相容性问题：

特定细胞类型、培养条件、研究目标和自动化细胞培养技术之间可能存在不相容性。这种不相容性可能会让人对系统效能、再现性和可靠性产生怀疑，并可能阻碍该技术在各种应用中的广泛采用。

监理合规课题：

自动化细胞培养系统的製造商和使用者在满足细胞培养流程、产品安全和资料完整性的严格监管要求和品质标准方面面临课题。这些障碍可能会导致我们产品的商业化和监管审批延迟。

客製化和灵活性限制：

某些自动化细胞培养系统可能无法客製化且不够灵活，无法满足特定的研究要求、实验布局或不断变化的科学趋势。因此，它们在动态研究环境中的可扩展性和有用性可能会受到限制。

资料安全问题：

由于自动化细胞培养系统本质上是数位化的，因此必须考虑资料安全、保密和隐私问题。特别是当涉及敏感研究资料和专有资讯时，组织必须实施强有力的网路安全保障措施并遵守资料保护法。

维护和营运成本：

消耗品、试剂和公用设施只是与自动化细胞培养系统相关的持续成本的一小部分。当这些成本加起来时，就会增加总拥有成本并降低成本效益。

技术过时的风险：

随着时间的推移，自动化技术和细胞培养方法的快速进步可能会使目前的自动化细胞培养系统过时或过时。保持竞争力并遵守行业标准需要持续投资于升级、更新和培训。

目录

第1章简介

• 市场定义
• 市场细分
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

第4章自动化细胞培养市场：依产品类型

• 自动化细胞培养系统
• 消耗品

第5章自动化细胞培养市场：依应用分类

• 药物发现和药物开发
• 生物製药製造
• 癌症研究
• 干细胞研究
• 组织工程

第6章 自动化细胞培养市场：依最终使用者分类

• 生物製药和生物技术公司
• 实验室和实验室
• 合约开发组织（CRO）
• 医院和诊断实验室

第7章 区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第8章市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第9章竞争格局

• 大公司
• 市场占有率分析

第10章 公司简介

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

第11章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第12章附录

• 缩写表
• 来源和参考文献

Automated Cell Cultures Market Size And Forecast

Automated Cell Cultures Market size was valued at USD 24.90 Billion in 2023 and is projected to reach USD 45.58 Billion by 2030, growing at a CAGR of 8.71% during the forecast period 2024-2030.

Global Automated Cell Cultures Market Drivers

The market drivers for the Automated Cell Cultures Market can be influenced by various factors. These may include: Demand for Biopharmaceuticals is Growing: In order to optimise production processes, automated cell culture technologies are becoming more and more necessary. Examples of these products include vaccinations, monoclonal antibodies, and recombinant proteins.

Technological Developments in Cell Culture:

The acceptance of automated cell culture solutions is being driven by the continuous development of sophisticated cell culture techniques, including the creation of bioreactors, automated systems, and advanced cell culture media.

Growing Prevalence of Chronic Diseases:

As chronic diseases like diabetes, cancer, and autoimmune disorders become more common, there is an increasing demand for effective cell culture methods for disease modelling, drug development, and personalised treatment.

Growing R&D Efforts in the Life Sciences:

As pharmaceutical and biotechnology businesses continue to spend in research and development to create new cures and treatments, the need for automated cell culture technologies to boost efficiency and productivity is growing.

Focus on Regenerative Medicine:

The increasing attention being paid to tissue engineering applications and regenerative medicine calls for accurate and regulated cell culture procedures, which is propelling the use of automated cell culture systems in the production of cell-based medicines and tissue-engineered goods.

Supportive government initiatives, funding programmes, and partnerships that promote biotechnology and life sciences research are helping to propel technological advancements and commercialization efforts, which in turn is driving the growth of the automated cell cultures market.

Need for Cost and Time Savings:

Automation in cell culture procedures reduces costs, reduces the possibility of human mistake, and quickens the time it takes for biopharmaceutical products to reach market. These benefits encourage the industry to adopt automated cell culture solutions.

Growing Need for Customised Medicine:

As a result of genomics and precision medicine breakthroughs, there is a growing need for scalable and repeatable cell culture systems that can generate patient-specific treatments. This is driving the market for automated cell culture technologies.

Global Automated Cell Cultures Market Restraints

Several factors can act as restraints or challenges for the Automated Cell Cultures Market. These may include:

High Initial Investment:

Smaller biotechnology companies and research institutes may find it difficult to enter the market due to the initial capital expenditure necessary for the acquisition and implementation of automated cell culture systems, which includes infrastructure, software, and equipment.

Complexity of Integration:

It can be difficult and time-consuming to integrate automated cell culture systems with current laboratory workflows and infrastructure. This is because it takes a lot of knowledge and resources for training, validation, and customisation, which lowers adoption rates.

Compatibility Concerns:

There may be incompatibilities between particular cell types, culture conditions, and research goals and automated cell culture technologies. These incompatibilities can raise questions about system performance, reproducibility, and reliability and prevent the technology from being widely adopted in a variety of applications.

Regulatory Compliance Challenges:

Manufacturers and users of automated cell culture systems face difficulties in adhering to strict regulatory requirements and quality standards that govern cell culture processes, product safety, and data integrity. These obstacles can cause delays in the commercialization of their products and regulatory approvals.

Limited Customisation and Flexibility:

Certain automated cell culture systems may not offer enough customisation and flexibility to meet specific research requirements, experimental layouts, or changing scientific trends. As a result, their scalability and usability in dynamic research environments may be limited.

Data Security Issues:

Since automated cell culture systems are digital in nature, there are data security, confidentiality, and privacy issues to be aware of. This is especially true for sensitive research data and proprietary information, which calls for the implementation of strong cybersecurity safeguards and adherence to data protection laws.

Maintenance and Operating Costs:

Consumables, reagents, and utilities are just a few of the ongoing costs that come with automated cell culture systems. These costs can add up to a substantial amount, which raises the total cost of ownership and reduces cost-effectiveness.

Risk of Technological Obsolescence:

Over time, rapid advancements in automation technologies and cell culture methodologies may make current automated cell culture systems obsolete or out of date. To stay competitive and adhere to industry standards, ongoing investments in upgrades, updates, and training are necessary.

Global Automated Cell Cultures Market Segmentation Analysis

The Global Automated Cell Cultures Market is Segmented on the basis of Product Type, Application, End User, and Geography.

Automated Cell Cultures Market, By Product Type

• Automated Cell Culture Systems:
• These encompass fully integrated systems designed to automate various aspects of cell culture, including cell seeding, media exchange, monitoring, and harvesting, offering increased efficiency, reproducibility, and scalability.
• Consumables:
• Consumables such as culture media, reagents, sera, and disposables play a crucial role in automated cell culture workflows, ensuring optimal cell growth, viability, and productivity.

Automated Cell Cultures Market, By Application

• Drug Discovery and Development:
• Automated cell culture systems are extensively used in drug discovery and development processes, including target identification, compound screening, toxicity testing, and lead optimization, facilitating high-throughput screening and accelerated drug development timelines.
• Biopharmaceutical Production:
• Automated cell culture technologies are employed in biopharmaceutical production processes for the large-scale manufacturing of therapeutic proteins, monoclonal antibodies, vaccines, and cell-based therapies, enabling efficient and consistent production yields.
• Cancer Research:
• Automated cell culture systems are utilized in cancer research applications for culturing tumor cells, studying tumor biology, drug response profiling, and screening anticancer agents, contributing to advancements in cancer diagnosis and treatment.
• Stem Cell Research:
• Automated cell culture technologies play a pivotal role in stem cell research applications, including pluripotent stem cell maintenance, differentiation protocols, tissue engineering, and regenerative medicine, facilitating the development of novel cell-based therapies and tissue-engineered products.
• Tissue Engineering:
• Automated cell culture systems are utilized in tissue engineering applications for fabricating functional tissues and organs ex vivo, mimicking physiological conditions and supporting cell proliferation, differentiation, and organization into three-dimensional structures.

Automated Cell Cultures Market, By End User

• Biopharmaceutical and Biotechnology Companies:
• These companies utilize automated cell culture systems for drug discovery, bioprocess development, and biomanufacturing applications, aiming to enhance productivity, reduce costs, and accelerate time-to-market for biopharmaceutical products.
• Research Laboratories and Institutes:
• Academic and research institutions leverage automated cell culture technologies for basic research, translational studies, and preclinical investigations across various disciplines, contributing to scientific advancements and knowledge dissemination.
• Contract Research Organizations (CROs):
• CROs offer automated cell culture services to pharmaceutical, biotechnology, and academic clients for outsourced drug discovery, preclinical testing, and biomanufacturing projects, providing specialized expertise, infrastructure, and resources.
• Hospitals and Diagnostic Laboratories:
• These healthcare facilities employ automated cell culture systems for diagnostic testing, personalized medicine applications, and therapeutic interventions, supporting clinical decision-making and patient care.

Automated Cell Cultures Market, By Geography

• North America:
• Market conditions and demand in the United States, Canada, and Mexico.
• Europe:
• Analysis of the Automated Cell Cultures Market in European countries.
• Asia-Pacific:
• Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa:
• Examining market dynamics in the Middle East and African regions.
• Latin America:
• Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Automated Cell Cultures Market are:
• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Automated Cell Cultures Market, By Product Type

• Automated Cell Culture Systems
• Consumables

5. Automated Cell Cultures Market, By Application

• Drug Discovery and Development
• Biopharmaceutical Production
• Cancer Research
• Stem Cell Research
• Tissue Engineering

6. Automated Cell Cultures Market, By End User

• Biopharmaceutical and Biotechnology Companies
• Research Laboratories and Institutes
• Contract Research Organizations (CROs)
• Hospitals and Diagnostic Laboratories

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References